Table 2 Companies or institutions that provide molecular testing services or research kits for the detection HHV-8 infection.
Molecular testing & kits | ||
|---|---|---|
Company | Test | UtilityFive articles described testing |
Focus Diagnostics, Inc. Herndon, VA, USA | PCR, qualitative | Method for identifying individuals among HIV+ persons who are at increased risk for developing KS. "The results are for research use only, and should not be used for diagnostic purposes." |
ViraCor Laboratories Lee's Summit, MO, USA | Real-time PCR, quantitative (100 copies/ml to 1 × 1010 copies/ml) | Clinical diagnostics: Determination of HHV-8 primary infection and for determining the risk of developing KS among organ transplant patients and patients taking immune suppressive drugs. |
ARUP Laboratories Salt Lake City, UT, USA | Real-time PCR, qualitative (limit of detection: 1 in 100,000 cells) | Clinical diagnostics: To predict the development of KS, to aid differential diagnosis in other vascular neoplasms and inflammatory conditions that are histologically similar to KS, to diagnose PELs, and to monitor patients with immune compromise or dysregulation. |
LabPLUS Auckland City Hospital, New Zealand. | PCR, qualitative | Clinical diagnostics: Diagnosis in KS, PEL, MCD |
Medical Diagnostic Laboratories, L.L.C. Hamilton, NJ, USA | PCR, qualitative | Clinical diagnostics |
UT Southwestern Medical Center Dallas, TX, USA | Real-time PCR, qualitative | Clinical diagnostics |
Celonex Edmonton, Alberta, Canada | Single HHV-8 ViruChip™ | Gene expression |